Abstract
Background Medication misadventure is greatest at times of change such as the transition from hospital to community. Patients with heart failure are prone to medication misadventure due to polypharmacy, inappropriate medication use and frequent readmissions. Objective To identify the barriers encountered when implementing a Liaison Pharmacist facilitated post-discharge medication management service for patients with heart failure. Method A Liaison Pharmacist contacted the patient’s General Practitioner (GP), sent them a medication discharge summary and organised an appointment for the patient with the GP approximately 2 days post-discharge to make a Home Medicines Review (HMR) referral. The patient’s community pharmacist was also contacted, sent a medication discharge summary and requested to engage an accredited pharmacist to undertake the HMR. The Liaison Pharmacist arranged for the HMR report to be sent to the outpatient department clinic to enable assessment of outcomes at the outpatient department follow-up 12 weeks post-discharge. Main outcome measure: GP HMR referral rates. Results 90 patients were offered the service. Fifty-nine patients (66%) agreed to have their GP contacted with 56 GPs agreeing to order a HMR and 41 patients having an HMR post-discharge. Barriers to the implementation of a HMR post-discharge included: patient withdrawal, low GP awareness of the HMR process and conducting the HMR in a timely manner. Conclusion This study provides evidence for the feasibility of a post-discharge pharmacy service for patients with heart failure although barriers to implementation have been identified.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Campbell DJ. Heart failure: how can we prevent the epidemic? Med J Aust. 2003;179:422–5.
Bennett A, Brien J. Community liaison pharmacist role in the multi-disciplinary care of heart failure patients. Aust J Pharm. 2002;83:740–3.
Varma S, McElnay J, Hughes CM, Passmore AP, Varma M. Pharmaceutical care of patients with congestive heart failure: interventions and outcomes. Pharmacotherapy. 1999;19:861–9.
Stewart S, Pearson S, Horowitz JD. Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care. Arch Intern Med. 1998;158:1067–72.
Bennett A, Krass I, Brien J. The future burden of cardiovascular disease: what can pharmacists do? Aust J Pharm. 2005;86:166–9.
Michalsen A, Konig G, Thimme W. Preventable causative factors leading to hospital admission with decompensated heart failure. Heart. 1998;80:437–41.
Bennett A, Brien J. Community liaison pharmacist role in the multi-disciplinary care of heart failure patients. Aust J Pharm. 2002;83:740–3.
Australian Pharmaceutical Advisory Council. National guidelines to achieve the continuum of quality use of medicines between hospital and community. Canberra: Australian Pharmaceutical Advisory Council, Commonwealth Department of Health and Aged Care; 1998.
Australian Pharmaceutical Advisory Council. Guiding principles to achieve continuity in medication management. Canberra: Australian Pharmaceutical Advisory Council, Commonwealth Department of Health and Aged Care; 2005.
Wilson S, Ruscoe W, Chapman M, Miller R. General practitioner-hospital communications: a review of discharge summaries. J Qual Clin Pract. 2001;21(4):104–8.
Australian Council for Safety and Quality in Health Care. Second national report on patient safety: improving medication safety, (Roughead L and Semple S). Canberra: Australian Council for Safety and Quality in Health Care; 2002.
Katz E, Nicod P, Brunner HR, Waeber B. Changes in treatment during and after hospitalization in patients taking drugs for cardiovascular diseases. Cardiovasc Drugs Ther. 1996;10(2):189–92.
Koecheler JA, Abramowitz PW, Swin SE, Daniels CE. Indicators for the selection of ambulatory patients who warrant pharmacist monitoring. Am J Hosp Pharm. 1989;46(4):729–32.
Stowasser DA, McGuire TM, Petrie GM, Lauchlan RL, Collins D. Information quality: a major consideration in the development of medication liaison services. Aust J Hosp Pharm. 1997;27:362–6.
McGuire TM. A pharmaceutical care liaison model. Aust J Hosp Pharm. 1996;26:36–7.
Gilbert A, Roughead E, Beilby J, Mott K, Barratt J. Collaborative medication management services; improving patient care. Med J Aust. 2002;177:189–92.
Hargraves T, Bennett AA, Brien JE. Evaluating outpatient pharmacy services: a literature review of specialist heart failure services. Int J Pharm Pract. 2006;14:3–9.
Emblen G, Miller E. Home medicines review: the how and why for GPs. Aust Fam Physician. 2004;33(1/2):49–51.
Jaeschke D, Close A, Edwards S, Pecanek H. HMR online resource kit. Pharmacy Guild of Australia and Divisions of General Practice Limited. 2004. http://mail.andgp.org.au/hmr/. Viewed 18 May 2006
Roughead L, Semple S, Vitry A. The value of pharmacist professional services in the community setting: a systematic review of the literature 1990–2002. University of South Australia; 2003.
Ponniah A, Anderson B, Shakib S, Doecke C, Angley M. Pharmacists’ role in the post-discharge management of patients with heart failure—a literature review. J Clin Pharm Ther. 2007;32:1–10.
Holland R, Lenaghan E, Ashton K, Hay L, Smith R, Shepstone L, et al. Effectiveness of visits from community pharmacists for patients with heart failure: Heart Med randomised controlled trial. BMJ (online). 2007. doi:10.1136/bmj.39164.568183.AE.
Yu K, Nguyen A, Shakib S, Doecke C, Boyce M, March G, et al. Enhancing continuity of care: development of a post-discharge home medicines review model. J Pharm Pract Res. 2007;37(1):22–6.
Royal Adelaide Hospital. Royal Adelaide Hospital. Adelaide. 2006. <http://www.rah.sa.gov.au/homepage.php>. Viewed 10 October 2006.
Holland R, Lenghan E, Harvey I, Smith R, Shepstone L, Lipp A, et al. Does home based medication review keep older people out of hospital? The HOMER randomized controlled trial. BMJ. 2005;330(7486):293.
Zermansky AG, Petty DR, Raynor DK, Freemantle N, Vail A, Lowe CJ. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ. 2001;323:1340.
Petty DR, Knapp P, Raynor DK, House AO. Patients’ views of a pharmacist-run medication review clinic in general practice. Br J Gen Pract. 2003;53(493):607–13.
Petty DR, Zermansky AG, Raynor DK. ‘No thank you’: why elderly patients declined to participate in a research study. Pharm World Sci. 2001;23:22–7.
Emerson L. HMRs—the next five years? Pharm Rev. 2005;29(2):36–9.
Grimmer K, Hedges G, Moss J. Staff perceptions of discharge planning: a challenge for quality improvement. Aust Health Rev. 1999;22(3):95–109.
Seston EM, Tully MP, Cantrill J. Barriers to the implementation of pharmacist-run prescription monitoring and review services. Pharm J. 1999;263(7063):12–3.
Cochrane R, Mandal A, Ledger-Scott M, Walker R. Changes in drug treatment after discharge from hospital in geriatric patients. BMJ. 1992;305:694–6.
Frankyl SE, Breeling JL, Goldman L. Preventability of emergent hospital readmissions. Am J Med. 1991;90:667–74.
Gowan J, Roller L. Chronic disease self management and home medicines reviews. Aust J Pharm. 2004;85:131–3.
Acknowledgements
The assistance provided throughout the project by Ms. Olimpia Nigro, Senior Clinical Pharmacist, Royal Adelaide Hospital, is acknowledged with gratitude.
Funding
This study was supported by the Sansom Institute, University of South Australia and the Royal Adelaide Hospital.
Conflict of interest
None declared
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ponniah, A., Shakib, S., Doecke, C.J. et al. Post-discharge medication reviews for patients with heart failure: a pilot study. Pharm World Sci 30, 810–815 (2008). https://doi.org/10.1007/s11096-008-9230-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-008-9230-7